Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marija Balic

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Molecular Oncology|December 2, 2020
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR<sup>+</sup> breast cancer patients undergoing CDK4/6 treatmentNadia Dandachi, Florian Posch, Ricarda Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Onkologie|September 15, 2010
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodiesJoanna Szkandera, Ferdin Ploner, Thomas Bauernhofer, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomasNadia Dandachi, Verena Tiran, Joerg Lindenmann, et al.
Oncotarget|December 2, 2017
Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patientsTheresa Benezeder, Verena Tiran, Alexandra A N Treitler, et al.
British Journal of Cancer|April 28, 2020
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict testsStephan Wenzel Jahn, Andreas Bösl, Oleksiy Tsybrovskyy, et al.
Annals of Surgery|May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE TrialFlorian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
European Urology|September 19, 2009
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profilesMarc Birkhahn, Anirban P Mitra, Anthony J Williams, et al.
Scientific Reports|September 1, 2017
Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transitionVerena Tiran, Joerg Lindenmann, Luka Brcic, et al.
Annals of Surgical Oncology|August 28, 2019
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant TherapyHannah Deborah Müller, Florian Posch, Christoph Suppan, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Molecular Oncology|December 2, 2020
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR<sup>+</sup> breast cancer patients undergoing CDK4/6 treatmentNadia Dandachi, Florian Posch, Ricarda Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Onkologie|September 15, 2010
Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodiesJoanna Szkandera, Ferdin Ploner, Thomas Bauernhofer, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomasNadia Dandachi, Verena Tiran, Joerg Lindenmann, et al.
Oncotarget|December 2, 2017
Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patientsTheresa Benezeder, Verena Tiran, Alexandra A N Treitler, et al.
British Journal of Cancer|April 28, 2020
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict testsStephan Wenzel Jahn, Andreas Bösl, Oleksiy Tsybrovskyy, et al.
Annals of Surgery|May 15, 2019
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE TrialFlorian Fitzal, Vesna Bjelic-Radisic, Michael Knauer, et al.
European Urology|September 19, 2009
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profilesMarc Birkhahn, Anirban P Mitra, Anthony J Williams, et al.
Scientific Reports|September 1, 2017
Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transitionVerena Tiran, Joerg Lindenmann, Luka Brcic, et al.
Annals of Surgical Oncology|August 28, 2019
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant TherapyHannah Deborah Müller, Florian Posch, Christoph Suppan, et al.
Pageof 13